Two Sigma Securities »

Sensei Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $12k 19k 0.62

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Sensei Biotherapeutics

Ikarian Capital
Vanguard Group
Renaissance Technologies
Geode Capital Management
Susquehanna International
Bridgeway Capital Management
Citadel Advisors
National Bank Of Canada /fi/
Northern Trust
State Street Corporation
Raymond James & Associates
Two Sigma Securities
Morgan Stanley
Deuterium Capital Management
BlackRock

View all funds holding Sensei Biotherapeutics